Ingrida RUMBA
Born: September 16, 1959
Interests:
- Epidemiology of chronic diseases in children , immunogenetics in autoimmune diseases
(juvenile arthritis, insulin dependent diabetes mellitus)
- Viruses in juvenile arthritis
- Medical education research
- Children chronic diseases risk factors, outcomes and damage studies
- Children morbidity, mortality and its structure in Latvia.
My major research fields are paediatric chronic diseases, rheumatology and autoimmune
diseases studying epidemiology, genetic markers, viruses in pathogenesis, outcomes and
prognostic factors. I am very involved into medical education so I am doing research in
this area although. I am supervisor of 3 research students.
Languages: Latvian, Russian (fluent), English (fluent), German (fluent)
Education:
Riga Medical Institute, Faculty of Paediatrics, (diploma of physician), 1983
Riga Medical Institute, Faculty of Paediatrics, postgraduate training in paediatrics,
1983-1985
Moscow Institute of Rheumatology, PhD student, 1985-1988
Dr.med. (Candidate of Science in former USSR, PhD in Western countries),
institute of Rheumatology, Moscow,1990
Thesis Clinical and genetic
investigation of juvenile Rheumatoid arthritis
Dr.habil.med., Medical Academy of Latvia, 1996
Thesis Epidemiology, immunogenetics
and prognosis of Juvenile Chronic Arthritis (JCA)
Employment:
- Assistant at Department of Paediatrics, Medical Academy of Latvia (AML), 1988-1992
- Docent at Department of Paediatrics, Medical Academy of Latvia (AML), 1992-1998
- Dean of the Faculty of Paediatrics , AML, 1990-1993
- Vice-Dean of the Faculty of General Medicine, AML, 1993-1997
- Chair of Department of Paediatrics, AML, 1993-1998
- Professor of Paediatrics at the Faculty of Medicine, University of Latvia, 1998-
- Vice dean, Faculty of Medicine, University of Latvia , 1999-
- Head of Paediatric Clinic, Children Hospital Gailezers, 2003-
Abroad:
- Basel University Paediatric hospital, March- April 1989
- Karolinska Institute, Centre Molecular Medicine, October 1995
- Karolinska Hospital, Astrid Lindgren Children Hospital, November 1998
Honours and Awards
Professional Activities and Memberships:
- Member of Council, Faculty of Medicine
- Chair, Council of Study programme, Faculty of Medicine
- Member, Academic Commission of Natural Sciences, University of Latvia
- President, Children Rheumatologists Society, Latvia
- Pediatric Society of Latvia (Member of Council, Member of Certification Commission),
- Physician Society of Latvia , Sertification Council, member (until 2002)
- Physician Society of Latvia, Member of Teaching Commission
- Chair of Paediatrics Professors group, Faculty of Medicine, University of Latvia
- Chair of Paediatric Clinic, Faculty of Medicine, University of Latvia
- Member, Scientific Commitee of PRES Congress in Geneva, 2000
- Member, Scientific Commitee of 4th World Latvian Physicians Congress
- Member of Pediatric Commitee, EULAR
- Member, PRES (Pediatric Rheumatology European Society)
Professional licences :
- licence of Paediatrician
- licence of Rheumatologist
- licence of Paediatric Rheumatology
Conferences:
- European Paediatric rheumatology annual scientific meeting (member of scientific
committee), Geneva, 2000
- 4th World Latvian Physicians congress (member of scientific committee), Riga,
2001.
Study courses:
- since 1998: pediatrics I, Higher Professional Educational Study Programme in Medicine
- 1998-2002: study course in pediatrics and pediatric rheumatology for general
practitioners
- since 2001: study course for general practitioners Specific health problems of
newborns, infants and children
- since 1998: chair of Study programme Council at Faculty of Medicine, University of
Latvia
Created study courses:
- pediatrics, Higher Professional Educational Study Programme in Medicine
- Specific health problems of newborns, infants and children, continuing medical education
programme for general practitioners
- Feeding of children and adolescents, Master programme for dieticians
Created study programmes:
- Higher Professional Educational Study Programme in Medicine (accreditation for 6 years)
- Postgraduate educational programme in pediatrics (accreditation for 6 years)
- Project: continuing medical education programme for general practitioners (Latvia health
care reorganization) (World Bank foundation, agreement Latvia/Health/B2A#O42/CLC/IBRD)
(approved at LU Senate)
Recent (representative) publications:
Research grants:
National:
- (Head of Project). Viruses in juvenile arthrtitis patients. Latvian Council of
Science: grant Nr.461/01.0251.
- (Head of Project). Virus associated juvenile arthritis: pathogenesis study. Latvian
Council of Science: grant Nr.04.1312.
- MICA and MICB microsatellites and MICA extracellular polymorphisms in Juvenile arthritis
patients.
International:
- EU project: Prospective validation of the juvenile systemic lupus erythematosus (JSLE)
and juvenile dermatomyositis (JDM) disease activity (DA) and disease damage (DD) core sets
of outcome measure (QLG1-CT-2000-00514)
- EU project: European information network on paediatric rheumatic diseases
(QLG1-CT-2000-00514)
- SOCRATES ERASMUS: Mednet (Medical Education and Didactics Network)
(213869-CP-1-2002-1-IT-ERASMUS-TN)
- EU Leonardo da Vinci project CLEAR: Survey Education system for medical doctors
and existing postgraduate courses in Latvia
- KIRT: (Karolinska Institute Reserch and Training Commitee) (Stockholm) and Latvia joint
PhD project coordinator
- KIRT project: Studies on Autoimmune Diabetes in Latvians and other Populations
- KIRT project: Helicobacter pylori infection among children in Riga, Latvia
- PRINTO (Paediatric Rheumatology International Trial Organization) project:
Cross-cultural adaptation and validation the Childhood Health Assessment Questionnaire
(CHAQ) and the Child Health Questionnaire (CHQ)
- PRINTO project: A randomised trial of 6 months verus 12 montns withdrawal of
methotrexate (MTX) in patients with juvenile idiopatnic arthritis (JIA) in clinical
remission.
- PRINTO project: Juvenile dermatomyosits (JDM): 5-year phase II single-blind, randomized
clinical trial in children with newlydiagnosed JDM: prednisone (PDN) versus PDN plus
methotrexate (MTX) versus PDN plus Cyclosporine A. Juvenile systemic lupus erythematosus
(JSLE): 5 year phase II single-blind, randomized clinical trial in children with newly
diagnosed, WHO class III and IV JSLE proliferative nephritis: PDN and oral
cyclophosphamide (CYC) versus high dose intravenous (iv) CYC) versus intermediate dose iv
CYC, followed by maintenance with azathioprine.
- EMA (European Medical association) project: EPOWEB (European Post graduate on the WEB)
- Project: Continuing education of general practitioners (Latvia health care
reorganization) (World Bank foundation, agreement Latvia/Health/B2A#O42/CLC/IBRD)
- Clinical trial Efficacy and tolerability of different dosages Mildronate syrup in
children (GRM_97-03), expert
|
|
Last update 08.03.2007